FMS Relative Valuation
FMS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, FMS is overvalued; if below, it's undervalued.
Historical Valuation
Fresenius Medical Care AG (FMS) is now in the Undervalued zone, suggesting that its current forward PE ratio of 9.39 is considered Undervalued compared with the five-year average of 14.07. The fair price of Fresenius Medical Care AG (FMS) is between 36.30 to 50.87 according to relative valuation methord. Compared to the current price of 23.37 USD , Fresenius Medical Care AG is Undervalued By 35.61%.
Relative Value
Fair Zone
36.30-50.87
Current Price：23.37
35.61%
Undervalued
9.39
PE
1Y
3Y
5Y
Trailing
Forward
5.96
EV/EBITDA
Fresenius Medical Care AG. (FMS) has a current EV/EBITDA of 5.96. The 5-year average EV/EBITDA is 7.62. The thresholds are as follows: Strongly Undervalued below 5.59, Undervalued between 5.59 and 6.61, Fairly Valued between 8.64 and 6.61, Overvalued between 8.64 and 9.66, and Strongly Overvalued above 9.66. The current Forward EV/EBITDA of 5.96 falls within the Undervalued range.
10.37
EV/EBIT
Fresenius Medical Care AG. (FMS) has a current EV/EBIT of 10.37. The 5-year average EV/EBIT is 14.24. The thresholds are as follows: Strongly Undervalued below 9.35, Undervalued between 9.35 and 11.80, Fairly Valued between 16.69 and 11.80, Overvalued between 16.69 and 19.13, and Strongly Overvalued above 19.13. The current Forward EV/EBIT of 10.37 falls within the Undervalued range.
0.59
PS
Fresenius Medical Care AG. (FMS) has a current PS of 0.59. The 5-year average PS is 0.71. The thresholds are as follows: Strongly Undervalued below 0.30, Undervalued between 0.30 and 0.50, Fairly Valued between 0.91 and 0.50, Overvalued between 0.91 and 1.12, and Strongly Overvalued above 1.12. The current Forward PS of 0.59 falls within the Historic Trend Line -Fairly Valued range.
4.58
P/OCF
Fresenius Medical Care AG. (FMS) has a current P/OCF of 4.58. The 5-year average P/OCF is 5.42. The thresholds are as follows: Strongly Undervalued below 2.86, Undervalued between 2.86 and 4.14, Fairly Valued between 6.71 and 4.14, Overvalued between 6.71 and 7.99, and Strongly Overvalued above 7.99. The current Forward P/OCF of 4.58 falls within the Historic Trend Line -Fairly Valued range.
7.06
P/FCF
Fresenius Medical Care AG. (FMS) has a current P/FCF of 7.06. The 5-year average P/FCF is 8.67. The thresholds are as follows: Strongly Undervalued below 3.02, Undervalued between 3.02 and 5.85, Fairly Valued between 11.50 and 5.85, Overvalued between 11.50 and 14.32, and Strongly Overvalued above 14.32. The current Forward P/FCF of 7.06 falls within the Historic Trend Line -Fairly Valued range.
Fresenius Medical Care AG (FMS) has a current Price-to-Book (P/B) ratio of 0.45. Compared to its 3-year average P/B ratio of 0.71 , the current P/B ratio is approximately -36.74% higher. Relative to its 5-year average P/B ratio of 0.95, the current P/B ratio is about -52.92% higher. Fresenius Medical Care AG (FMS) has a Forward Free Cash Flow (FCF) yield of approximately 15.37%. Compared to its 3-year average FCF yield of 14.39%, the current FCF yield is approximately 6.76% lower. Relative to its 5-year average FCF yield of 13.58% , the current FCF yield is about 13.11% lower.
0.45
P/B
Median3y
0.71
Median5y
0.95
15.37
FCF Yield
Median3y
14.39
Median5y
13.58
Competitors Valuation Multiple
The average P/S ratio for FMS's competitors is 0.59, providing a benchmark for relative valuation. Fresenius Medical Care AG Corp (FMS) exhibits a P/S ratio of 0.59, which is 0.00% above the industry average. Given its robust revenue growth of 9.17%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of FMS increased by 3.22% over the past 1 year. The primary factor behind the change was an increase in Margin Expansion from 5.55 to 6.70.
The secondary factor is the Revenue Growth, contributed 9.17%to the performance.
Overall, the performance of FMS in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch
FAQ
Is Fresenius Medical Care AG (FMS) currently overvalued or undervalued?
What is Fresenius Medical Care AG (FMS) fair value?
How does FMS's valuation metrics compare to the industry average?
What is the current P/B ratio for Fresenius Medical Care AG (FMS) as of Dec 05 2025?
What is the current FCF Yield for Fresenius Medical Care AG (FMS) as of Dec 05 2025?
What is the current Forward P/E ratio for Fresenius Medical Care AG (FMS) as of Dec 05 2025?